Msi2 deletion resulted in the loss of the NHD13-expressing cells and a reversal of MDS-like disease that included an increase in white blood cell (WBC) counts, red blood cells and platelets (Fig. 2e–g). This evidence concerns the gene MSI2 and myelodysplastic syndrome.